What genetic conditions can cause persistent thinness and failure to gain weight from birth?

Genetic Causes of Thinness and Failure to Gain Weight from Birth

Chromosomal abnormalities, particularly Turner syndrome and its variants, represent the most common genetic cause of failure to thrive from birth, accounting for 19% of pathologic cases, followed by recognized multiple malformation syndromes (3%) and specific genetic disorders affecting growth and feeding. 1

Primary Genetic Categories to Consider

When evaluating persistent thinness and failure to gain weight from birth, the genetic differential diagnosis includes several distinct categories that require systematic evaluation:

Chromosomal Disorders (Most Common)

• Turner syndrome and variants are the leading chromosomal cause 1
• Other chromosomal abnormalities collectively represent the single largest pathologic category
• These should be evaluated first through chromosomal microarray or karyotype analysis

Microdeletion/Duplication Syndromes

22q11.2 deletion syndrome commonly presents with early deceleration of weight gain followed by stature issues, with feeding difficulties and failure to thrive contributing significantly to growth problems 2. The pattern typically shows:

• Early weight gain deceleration
• Less catch-up in stature compared to weight
• Mean height at age 19 years of -1.14 SD for females and -0.72 SD for males
• Short stature (<2.5th percentile) in a minority

Methylation Disorders

Prader-Willi syndrome presents paradoxically with severe hypotonia and poor suck resulting in failure to thrive during infancy before the later hyperphagia phase develops 3. This is caused by lack of expression of paternally inherited genes on chromosome 15q11.2-q13 and requires DNA methylation analysis for diagnosis.

RASopathies

Costello syndrome (HRAS gene mutations) characteristically shows:

• Prenatal overgrowth followed by postnatal failure to thrive
• Rapid weight loss that can be severe and refractory to hypercaloric diet
• Excessive energy needs leading to severe failure to thrive 4
• May mimic lipodystrophy with loss of fat tissue

Metabolic Syndromes

Inborn errors of metabolism associated with physical features or skeletal changes should be considered, particularly when accompanied by other systemic manifestations 1, 5.

Skeletal Dysplasias

These represent another category of genetic causes, particularly when intrauterine growth restriction (IUGR) is present 1.

Diagnostic Approach

The critical distinction is between insufficient intake (59% of cases), organic disease including genetic disorders (20%), and mechanical feeding difficulties (11%) 6. Importantly:

• Over 90% of insufficient intake cases are diagnosed during initial admission
• Only 65% of organic diseases and 39% of genetic disorders are diagnosed during initial admission 6

Key Clinical Indicators for Genetic Etiology

Patient factors strongly associated with genetic disorders include 6:

• Previous NICU stay
• Low birth weight
• Dysphagia
• Hypotonia (critical finding)
• Dysmorphic features

Growth Pattern Analysis

The most useful single indicator beyond absolute height is growth velocity 1:

• Crossing several centile lines between 3 years and late childhood suggests pathologic diagnosis
• Exception: Healthy large infants often cross centiles in first 3 years establishing appropriate genetic potential
• IUGR/SGA definition: length and weight <10th centile for gestational age

Common Pitfalls

The major diagnostic challenge is that genetic disease, especially specific genetic syndromes, is frequently missed during initial evaluation 6. This occurs because:

1. Dysmorphic features may be subtle or masked by severe malnutrition (as in Costello syndrome mimicking lipodystrophy) 4
2. The presenting complaint of poor weight gain overshadows other subtle physical findings
3. Initial focus on feeding mechanics and nutritional support delays genetic evaluation

A history of prenatal overgrowth with polyhydramnios followed by severe postnatal failure to thrive should immediately trigger consideration of RASopathies like Costello syndrome 4.

Testing Strategy

Based on the guideline framework 1 and research evidence:

1. First-line: Chromosomal microarray or karyotype (highest yield for Turner syndrome and other chromosomal abnormalities)
2. If dysmorphic features or hypotonia present: Consider whole exome sequencing early, as this has become the diagnostic tool for complex genetic syndromes 4
3. If specific syndrome suspected: Targeted testing (e.g., DNA methylation analysis for Prader-Willi syndrome 3)

Better tools and earlier genetic evaluation are needed, as current practice results in delayed diagnosis of organic disease in the majority of cases 6.